問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK3475-522
Active

2017-03-01 - 2019-12-31

Phase III

Terminated6

ICD-10C50

Malignant neoplasm of breast

ICD-9174.0

Malignant neoplasm of female breast, nipple and areola

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Chiun-Sheng Huang Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Audit

None

Principal Investigator Kuo-Ting Lee Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 張源清 Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 鍾奇峰 Division of Hematology & Oncology

Co-Principal Investigator

  • 褚乃銘 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Ling-Ming Tseng Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

7 Completed

Audit

None

Principal Investigator Shin-Cheh Chen Division of General Surgery
Linkou Chang Gung Medical Foundation

Taiwan National PI

陳訓徹

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

9 Completed

Audit

CRO

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    約50 participants

  • Global

    約855 participants